Nutex director reports RSU vesting, tax withholding

Nutex Health Inc. director Kelvin Spears reported compensation-related stock activity.

Rhea-AI Filing Summary

Nutex Health Inc. director Kelvin Spears reported compensation-related stock activity. He received 183 shares of common stock upon vesting of previously granted restricted stock units, with 82 of those shares withheld to cover tax obligations, leaving a net 101 new shares and bringing his direct common stock holdings to 32,127 shares.

He was also granted 116 new restricted stock units that each convert into one share of common stock and are scheduled to vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. These transactions are routine equity compensation events rather than open-market purchases or sales.

Insider Trade Summary

116 shares exercised/converted

Exercise 3 txns

Insider Spears Kelvin

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	116	$0.00	$0.00
Exercise	Common Stock	183	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	82	$86.2224	$7K

Holdings After Transaction: Restricted Stock Units — 421 contracts (Direct); Common Stock — 32,127 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. Of the 183 shares issued subsequent to vesting, 82 shares were sold to cover tax withholding obligations.
3. F3. On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kelvin Spears report for Nutex Health (NUTX)?

Kelvin Spears reported equity compensation activity, not open-market trading. Previously granted restricted stock units vested into 183 common shares, with 82 withheld for taxes. He also received 116 new restricted stock units scheduled to vest between 2027 and 2029.

How many Nutex Health (NUTX) shares does Kelvin Spears now hold directly?

After these transactions, Kelvin Spears directly holds 32,127 shares of Nutex Health common stock. This reflects the vesting of 183 shares and withholding of 82 shares for taxes, as disclosed, and provides context for his ongoing equity stake in the company.

Were Kelvin Spears’ Nutex Health (NUTX) transactions open-market buys or sells?

The transactions were not open-market buys or sells. They involved vesting and exercise of restricted stock units and a tax-withholding disposition of 82 shares, which were delivered to cover tax liabilities associated with the equity compensation event.

What new restricted stock units did Kelvin Spears receive from Nutex Health (NUTX)?

Kelvin Spears was granted 116 restricted stock units that convert into common stock on a one-for-one basis. These RSUs vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, aligning his compensation with long-term company performance.

Why were 82 Nutex Health (NUTX) shares disposed of in Kelvin Spears’ filing?

The 82 shares were withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units. This tax-withholding disposition is a standard mechanism in equity compensation plans and does not represent an open-market sale by the director.

How do Kelvin Spears’ RSUs convert into Nutex Health (NUTX) common stock?

Each restricted stock unit converts into one share of Nutex Health common stock. Upon vesting on scheduled dates in 2027, 2028, and 2029, the RSUs will settle in shares, subject to applicable tax withholding requirements at the time of vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 05:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spears Kelvin

(Last) (First) (Middle)

1776 YORKTOWN STREET

SUITE 700

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		183(1)	A	$0(1)	32,209	D
Common Stock	03/10/2026		F		82(2)	D	$86.2224	32,127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/10/2026		M		116(1)		03/01/2027(3)	03/01/2029(3)	Common Stock	116	$0	421	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Of the 183 shares issued subsequent to vesting, 82 shares were sold to cover tax withholding obligations.

3. On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Kelvin Spears	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.